Display options
Cite
Landlinger C, Tisakova L, Oberbauer V, et al. Engineered Phage Endolysin Eliminates . Pathogens. 2021;10(1)doi: 10.3390/pathogens10010054.
Landlinger, C., Tisakova, L., Oberbauer, V., Schwebs, T., Muhammad, A., Latka, A., Van Simaey, L., Vaneechoutte, M., Guschin, A., Resch, G., Swidsinski, S., Swidsinski, A., & Corsini, L. (2021). Engineered Phage Endolysin Eliminates . Pathogens (Basel, Switzerland), 10(1), . https://doi.org/10.3390/pathogens10010054
Landlinger, Christine, et al. "Engineered Phage Endolysin Eliminates ." Pathogens (Basel, Switzerland) vol. 10,1 (2021). doi: https://doi.org/10.3390/pathogens10010054
Landlinger C, Tisakova L, Oberbauer V, Schwebs T, Muhammad A, Latka A, Van Simaey L, Vaneechoutte M, Guschin A, Resch G, Swidsinski S, Swidsinski A, Corsini L. Engineered Phage Endolysin Eliminates . Pathogens. 2021 Jan 08;10(1). doi: 10.3390/pathogens10010054. PMID: 33435575; PMCID: PMC7830407.
Copy Download .nbib Format: NLM
Share it on

Pathogens. 2021 Jan 08;10(1). doi: 10.3390/pathogens10010054.

Engineered Phage Endolysin Eliminates .

Pathogens (Basel, Switzerland)

Christine Landlinger, Lenka Tisakova, Vera Oberbauer, Timo Schwebs, Abbas Muhammad, Agnieszka Latka, Leen Van Simaey, Mario Vaneechoutte, Alexander Guschin, Gregory Resch, Sonja Swidsinski, Alexander Swidsinski, Lorenzo Corsini

Affiliations

  1. PhagoMed Biopharma GmbH, Vienna Biocenter, 1110 Wien, Austria.
  2. Laboratory Bacteriology Research, Department of Diagnostic Sciences, Faculty of Medicine & Health Sciences, Ghent University, Flanders, 9000 Gent, Belgium.
  3. Department of Pathogen Biology and Immunology, Institute of Genetics and Microbiology, University of Wroclaw, 51-148 Wroclaw, Poland.
  4. Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology Moscow, 119071 Moscow, Russia.
  5. Department of Fundamental Microbiology, University of Lausanne, 1015 Lausanne, Switzerland.
  6. MDI Limbach Berlin GmbH, 13407 Berlin, Germany.
  7. Medizinische Klinik, Charité CCM, Humboldt Universität, 10117 Berlin, Germany.
  8. Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.

PMID: 33435575 PMCID: PMC7830407 DOI: 10.3390/pathogens10010054

Abstract

Bacterial vaginosis is characterized by an imbalance of the vaginal microbiome and a characteristic biofilm formed on the vaginal epithelium, which is initiated and dominated by

Keywords: Gardnerella biofilm; alternative to antibiotic treatment; antimicrobial resistance; bacterial vaginosis; endolysin; genus-specificity; prophage

Conflict of interest statement

Conflicts of interest have been declared by the following authors: CL, LT, VO are employees of PhagoMed Biopharma GmbH at the time of the study and LC holds shares in PhagoMed Biopharma GmbH and is th

References

  1. J Infect Dis. 2014 Aug 1;210(3):338-43 - PubMed
  2. ISME J. 2019 May;13(5):1306-1317 - PubMed
  3. Int J STD AIDS. 2009 Nov;20(11):778-81 - PubMed
  4. J Clin Microbiol. 1992 Mar;30(3):663-6 - PubMed
  5. Nat Rev Urol. 2016 Oct;13(10):596-607 - PubMed
  6. Viruses. 2018 Jun 07;10(6): - PubMed
  7. J Infect Dis. 2016 Aug 15;214 Suppl 1:S14-20 - PubMed
  8. Obstet Gynecol. 2005 Nov;106(5 Pt 1):1013-23 - PubMed
  9. Res Microbiol. 2017 Nov - Dec;168(9-10):811-825 - PubMed
  10. Future Microbiol. 2012 Oct;7(10):1147-71 - PubMed
  11. J Infect Dis. 2015 Dec 15;212(12):1856-61 - PubMed
  12. Lancet Infect Dis. 2017 Aug;17(8):e235-e279 - PubMed
  13. Nat Med. 2019 Oct;25(10):1500-1504 - PubMed
  14. Microb Biotechnol. 2011 Sep;4(5):651-62 - PubMed
  15. Int J Med Microbiol. 2010 Aug;300(6):357-62 - PubMed
  16. Int J Antimicrob Agents. 2016 Jul;48(1):1-10 - PubMed
  17. J Clin Invest. 1979 May;63(5):828-35 - PubMed
  18. Trends Microbiol. 2017 Mar;25(3):182-191 - PubMed
  19. Am J Obstet Gynecol. 2019 Jan;220(1):91.e1-91.e8 - PubMed
  20. Appl Environ Microbiol. 1990 Jun;56(6):1919-25 - PubMed
  21. Hum Reprod. 2013 Jul;28(7):1809-15 - PubMed
  22. Pathog Dis. 2018 Dec 1;76(9): - PubMed
  23. Sci Rep. 2019 Oct 1;9(1):14095 - PubMed
  24. PLoS Pathog. 2020 Jan 23;16(1):e1008236 - PubMed
  25. Histol Histopathol. 2014 May;29(5):567-87 - PubMed
  26. Antimicrob Agents Chemother. 2015 Dec;59(12):7447-57 - PubMed
  27. Am J Obstet Gynecol. 2013 Dec;209(6):505-23 - PubMed
  28. Adv Virus Res. 2012;83:299-365 - PubMed
  29. Mil Med Res. 2016 Feb 13;3:4 - PubMed
  30. Gynecol Obstet Invest. 2010;70(4):256-63 - PubMed
  31. Front Cell Infect Microbiol. 2020 Apr 24;10:168 - PubMed
  32. Anaerobe. 2017 Oct;47:115-119 - PubMed
  33. BJOG. 2019 Feb;126(3):349-358 - PubMed
  34. Infect Immun. 2019 Nov 18;87(12): - PubMed
  35. J Infect Dis. 1997 Feb;175(2):406-13 - PubMed
  36. Front Cell Infect Microbiol. 2020 Jun 23;10:293 - PubMed
  37. J Infect Dis. 2014 May 1;209(9):1469-78 - PubMed
  38. J Infect Dis. 2016 Aug 15;214 Suppl 1:S29-35 - PubMed
  39. PLoS One. 2016 Nov 18;11(11):e0166757 - PubMed
  40. BJOG. 2019 Jan;126(2):200-207 - PubMed
  41. Int J Mol Sci. 2013 Jun 05;14(6):12004-12 - PubMed
  42. Diagn Microbiol Infect Dis. 2016 Jan;84(1):1-3 - PubMed
  43. J Virol. 2013 Apr;87(8):4558-70 - PubMed
  44. Lancet. 2007 Jun 9;369(9577):1961-71 - PubMed
  45. Mol Diagn Ther. 2019 Feb;23(1):139-147 - PubMed
  46. Infect Immun. 2012 Jan;80(1):62-73 - PubMed
  47. J Infect Dis. 2019 Sep 26;220(9):1399-1405 - PubMed
  48. Sci Rep. 2015 Jun 26;5:11640 - PubMed
  49. Am J Med. 1983 Jan;74(1):14-22 - PubMed
  50. Int J Syst Evol Microbiol. 2019 Mar;69(3):679-687 - PubMed
  51. Am J Obstet Gynecol. 2008 Jan;198(1):97.e1-6 - PubMed
  52. J Infect Dis. 2014 Aug 15;210(4):593-6 - PubMed
  53. J Med Microbiol. 1989 Jul;29(3):229-35 - PubMed
  54. Arch Gynecol Obstet. 2015 Mar;291(3):605-9 - PubMed
  55. Best Pract Res Clin Obstet Gynaecol. 2007 Jun;21(3):375-90 - PubMed

Publication Types

Grant support